ROCKVILLE, MD--(Marketwire - November 12, 2007) - GlobalStem, Inc. is proud to announce it has been awarded two Phase 1 SBIR grants by the U.S. National Institutes of Health (NIH). The first grant titled, “Propagation and Characterization of 2 Mouse Embryonic Stem Cell Lines,” will affiliate GlobalStem with a trans-NIH initiative called the Knockout Mouse Project (KOMP) and will make scientifically valuable mouse embryonic stem (ES) cell lines available for research. The second grant titled, “Engineering a non-selective microenvironment for human embryonic stem cells (hESC),” will allow GlobalStem to create genetically modified human feeder cells for the support of undifferentiated hESC.
